Biocorp

Report Publication Announcement • Jan 9, 2020

BIOCORP: 2020 financial calendar

Issoire, France, January 9th, 2020, 08h00 am CET – BIOCORP (FR0012788065 – ALCOR / Eligible PEA PME), a French company specialized in the development and manufacturing of medical devices and smart drug delivery systems, updates its financial reporting schedule for 2020* :

Annonce	Date*
2019 full-year results	9th, 2020 Thursday, April Before the market opening
Annual shareholders meeting	15th, Friday, May 2020
2020 first-half results	Thursday, September 24th, 2020 After the market close

* This schedule is indicative and subject to change.

À PROPOS DE BIOCORP

Recognized for its expertise in the development and manufacture of medical devices and delivery systems, BIOCORP has today acquired a leading position in the connected medical device market thanks to Mallya. This intelligent sensor for insulin injection pens allows reliable monitoring of injected doses and thus offers better compliance in the treatment of diabetics. Available for sale from 2020, Mallya spearheads BIOCORP's product portfolio of innovative connected solutions. The company has 54 employees. BIOCORP is listed on Alternext since July 2015 (FR0012788065 – ALCOR). For more information, please visit www.biocorpsys.com Follow us on Twitter @BIOCORPSystems

BIOCORP CONTACTS Jacques Gardette Éric Dessertenne Sylvaine Dessard investisseurs@biocorp.fr rp@biocorp.fr

Chairman of the Board CEO Marketing @ Communication Director + 33 (0)6 88 69 72 85

ULYSSE COMMUNICATION CONTACTS Bruno ARABIAN Nicolas DANIELS barabian@ulysse-communication.com ndaniels@ulysse-communication.com +33 (0)6 87 88 46 26 +33 (0)6 63 66 59 22